Allelic diversity and affinity variants of MICA are imbalanced in Spanish patients with Behçet's disease

Scandinavian Journal of Immunology

Volumn 64, Issue 1, 2006, Pages 77-82

  Munoz Saa I ^a   Cambra, A ^a   Pallares L ^a   Espinosa, G ^b   Juan, A ^c   Pujalte, F ^a   Matamoros, N ^a   Mila J ^a   Julia M R ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL SON LLÀTZER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2D; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN RECEPTOR; MHC CLASS I RELATED CHAIN A; MHC CLASS I-RELATED CHAIN A; NATURAL KILLER CELL ACTIVATING RECEPTORS;

ALLELISM; ARTICLE; BEHCET DISEASE; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HOMOZYGOTE; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICA GENE; NORTH AFRICA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SPAIN; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETICS; HAPLOTYPE; IMMUNOLOGY;

BEHCET SYNDROME; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-B ANTIGENS; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, IMMUNOLOGIC; SPAIN;

EID: 33746416770     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2006.01780.x     Document Type: Article

References (42)

1. Suzuki Kurokawa M, Suzuki N. Behcet's disease. Clin Exp Med 2004;4:10-20.
2. Evereklioglu C. Current concepts in the etiology and treatment of Behcet Disease. Surv Ophthalmol 2005;50:297-350.
3. Eiroa P, Sánchez J, Rosales M et al. Estudio epidemiológico de la enfermedad de Behçet en el área sanitaria de La Coruña. Rev Esp Reumatol 1991;18:285-7.
4. International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990;335:1078-80.
5. Barnes CG, Yazici H. Behçet's syndrome. Rheumatology (Oxford) 1999;38:1171-6.
6. Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol 1982;100:1455-8.
7. Gonzalez-Escribano MF, Rodriguez MR, Walter K, Sanchez-Roman J, Garcia-Lozano JR, Nunez-Roldan A. Association of HLA-B51 subtypes and Behcet's disease in Spain. Tissue Antigens 1998;52:78-80.
8. Ota M, Mizuki N, Katsuyama Y et al. The critical region for Behcet Disease in the Human Major Histocompatibility Complex is reduced to a 46 kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping. Am J Hum Genet 1999;64:1406-10.
9. Available at: http://www.anthonynolan.com/HIG/seq/nuc/text/mica_nt.txt, 2006.
10. Mizuki N, Ota M, Kimura M et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet disease. Proc Natl Acad Sci USA 1997;94:1298-303.
11. Steinle A, Li P, Morris DL et al. Interactions of human NKG2D with its ligands MICA, MICB and homologs of the mouse RAE-1 protein family. Immunogenetics 2001;53:279-87.
12. Li P, Bauer S, Morris D, Spies T, Strong R. Crystal structure of the class I homolog MIC-A, a γδ T cell ligand. Immunity 1999;10:1-20.
13. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A 1996;93:12445-50.
14. Bauer S, Groh V, Wu J et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999;285:727-9.
15. Collins RWM. Human MHC class I chain related (MIC) genes: their biological function and relevance to disease and transplantation. Eur J Immunogenet 2004;31:105-14.
16. Yabuki K, Mizuki N, Ota M et al. Association of MICA gene and HLA-B*5101 with Behcet's disease in Greece. Invest Ophthalmol Vis Sci 1999;40:1921-6.
17. Mizuki N, Ota M, Katsuyama Y et al. Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behcet's disease. Arthritis Rheum 1999;42:1961-6.
18. Marin ML, Savioli CR, Yamamoto JH, Kalil J, Goldberg AC. MICA polymorphism in a sample of the Sao Paulo population, Brazil. Eur J Immunogenet 2004;31:63-71.
19. Wallace GR, Verity DH, Delamaine LJ et al. MIC-A allele profiles and HLA class I associations in Behcet's disease. Immunogenetics 1999;49:613-7.
20. Park SH, Park KS, Seo YI et al. Association of MICA polymorphism with HLA-B51 and disease severity in Korean patients with Behcet's disease. J Korean Med Sci 2002;17:366-70.
21. Hughes EH, Collins RW, Kondeatis E et al. Associations of major histocompatibility complex class I chain-related molecule polymorphisms with Behcet's disease in Caucasian patients. Tissue Antigens 2005;66:195-9.
22. Gonzalez-Escribano MF, Rodriguez MR, Aguilar F, Alvarez A, Sanchez-Roman J, Nunez-Roldan A. Lack of association of MICA transmembrane region polymorphism and Behcet's disease in Spain. Tissue Antigens 1999;54:278-81.
23. Ahmad T, Marshall SE, Mulcahy-Hawes K et al. High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibility. Tissue Antigens 2002;60:164-79.
24. Stephens HA, Vaughan RW, Collins R, Kondeatis E, Theron J, Payne A. Towards a molecular phototyping system for allelic variants of MICA, encoded by polymorphisms in exons 2, 3 and 4 of MHC class I chain-related genes. Tissue Antigens 1999;53:167-74.
25. Yao Z, Volgger A, Keller E, Chandanayingyong D, Albert ED. Allelic variation in the intron 2 and 3 of the MICA gene. J Biol Regul Homeost Agents 1999;13:47-50.
26. Shao W, Lobashevsky ES, Kaslow RA, Dorak MT. MICA intron 1 sequences of conserved extended HLA haplotypes: implications for sequencing-based typing. Genes Immun 2004;5:371-4.
27. Crespi C, Mila J, Martinez-Pomar N et al. HLA polymorphism in a Majorcan population of Jewish descent: comparison with Majorca, Minorca, Ibiza (Balearic Islands) and other Jewish communities. Tissue Antigens 2002;60:282-91.
28. Piancatelli D, Del Beato T, Oumhani K, El Aouad R, Adorno D. MICA polymorphism in a population from north Morocco, Metalsa Berbers, using sequence-based typing. Hum Immunol 2005;66:931-6.
29. Zhang Y, Han M, Vorhaben R, Giang C, Lavingia B, Stastny P. Study of MICA alleles in 201 African Americans by multiplexed single nucleotide extension (MSNE) typing. Hum Immunol 2003;64:130-6.
30. Petersdorf EW, Shuler KB, Longton GM, Spies T, Hansen JA. Population study of allelic diversity in the human MHC class I-related MIC-A gene. Immunogenetics 1999;49:605-12.
31. Arnaiz-Villena A, Benmamar D, Alvarez M et al. HLA allele and haplotype frequencies in Algerians. Relatedness to Spaniards and Basques. Hum Immunol 1995;43:259-68.
32. Hue S, Mention JJ, Monteiro RC et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004;21:367-77.
33. Groh V, Bruhl A, El-Gabalawy H, Nelson JL, Spies T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci U S A 2003;100:9542-7.
34. Ogasawara K, Hamerman JA, Ehrlich LR et al. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 2004;20:757-67.
35. McInnes IB, Gracie JA. Interleukin-15: a new cytokine target for the treatment of inflammatory diseases. Curr Opin Pharmacol 2004;4:392-7.
36. Wiemann K, Mittrucker HW, Feger U et al. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo. J Immunol 2005;175:720-9.
37. Oppenheim DE, Roberts SJ, Clarke SL et al. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat Immunol 2005;6:928-37.
38. Amroun H, Djoudi H, Busson M et al. Early-onset ankylosing spondylitis is associated with a functional MICA polymorphism. Hum Immunol 2005;66:1057-61.
39. Ricci-Vitiani L, Vacca A, Potolicchio I et al. MICA gene triplet repeat polymorphism in patients with HLA-B27 positive and negative ankylosing spondylitis from Sardinia. J Rheumatol 2000;27:2193-7.
40. Goto K, Ota M, Maksymowych WP et al. Association between MICA gene A4 allele and acute anterior uveitis in white patients with and without HLA-B27. Am J Ophthalmol 1998;126:436-41.
41. Gonzalez S, Brautbar C, Martinez-Borra J et al. Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population. Hum Immunol 2001;62:632-8.
42. Sohn S. Etiopathology of Behcet's disease: herpes simplex virus infection and animal model. Yonsei Med J 1997;38:359-64.